Methodological Experimental Study on Percutaneous Regional Isolated Hepatic Perfusion Combined with Charcoal Hemoperfusion

刘士辰,杨仁杰,张宏志,朱林忠
DOI: https://doi.org/10.3969/j.issn.1002-1671.2003.03.001
2003-01-01
Abstract:Objective To investigate methods and feasibility of percutaneous regional isolated hepatic perfusion combined with charcoal hemoperfusion(PRIHP-CHP).Methods Four out of 12 dogs underwent the procedure of routine transhepatic arterial infusion(TAI) as control group, 8 underwent PRIHP-CHP as experimental group. Adriamycin was used in our study, the concentration of plasma in hepatic vein and systemic vein was detected in both groups. Results All the procedures were successful in the PRIHP-CHP group eight, but 1 dog died because of air embolization. The average procedure duration for each was (132.3±15.3) minutes. The peak level of adriamycin concentration in hepatic vein and systemic in TAI were (3709.676±385.723) ng/ml and (1576.140±226.933) ng/ml respectively. In PRIHP-CHP, the peak level were (4653.420±430.204) ng/ml and (433.612±40.501) ng/ml. There were statistically significant differences between TAI and PRIHP-CHP (Ρ0.01). Conclusion PRIHP-CHP is a feasible method which has many advantages such as simple, minimally invasive, normal liver can be protected, easy for retreatment. Compared with TAI, using the technology of PRIHP-CHP, the concentration of chemotherapeutic agents can increase in regional liver, and even more markedly decrease in systemic circulation.
What problem does this paper attempt to address?